New drug approvals, generic expansion, high-potency API demand, and the continued globalization of pharmaceutical manufacturing present lucrative business opportunities Small Molecule API ...

The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...

RPG Life Sciences announced that its wholly owned subsidiary, RPG Active Pharma (RPGAP), has entered into a Business Transfer Agreement to acquire the Active Pharmaceutical Ingredients (API) and ...

RPG Active Pharma strengthens its API presence by acquiring Raghava Life Sciences' API business, enhancing growth and ...

Manufacturers and contract development and manufacturing organizations are developing processes and facilities to meet growing specialty API demand. For decades, APIs, the foundation of the ...

Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business in Jeedimetla ...

Manufacturers in Europe and the United States have announced plans for new in-country API development and manufacturing capabilities. Manufacturers in Europe and the United States have announced plans ...

China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...

MARLBOROUGH, Mass., Nov. 30, 2018 /PRNewswire/ — API Technologies Corp. (“API”), a leading provider of high performance RF and microwave signal conditioning and electromagnetic spectrum management ...